EDITEditas Medicine, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 14612
Ticker: EDIT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2016-02-03
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: EDIT

Detail

Enriched 2026-08-14 20:47

Market cap: $436,167,299.4
Shares outstanding (class): 153,580,035
Shares outstanding (weighted): 153,580,035
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 87
Location: CAMBRIDGE, MA
Homepage: https://www.editasmedicine.com
Description: Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Market cap and share counts drift.

Funds holding this security

81 funds · 81 positions · $33.35M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$7.46M	0.00%	3,019,044 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$5.87M	0.01%	2,377,986 NS	FIGI
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$4.62M	0.05%	1,872,176 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$2.66M	0.00%	1,076,238 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$2.09M	0.02%	846,943 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$1.81M	0.02%	731,163 NS	FIGI
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS	—	$1.03M	0.04%	415,301 NS	FIGI
JPMorgan U.S. Small Company Fund JPMorgan Trust I	—	$738.5K	0.08%	298,969 NS	FIGI
JPMorgan Small Cap Value Fund JPMorgan Trust II	—	$730.8K	0.06%	295,867 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$611.6K	0.05%	247,613 NS	FIGI
BlackRock Advantage Small Cap Growth Fund BlackRock Funds	—	$466.0K	0.07%	188,660 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$352.6K	0.01%	142,742 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$311.2K	0.25%	126,000 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$301.7K	0.02%	122,141 NS	FIGI
SMALL CAP EQUITY FUND GuideStone Funds	—	$267.3K	0.03%	108,218 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKEREDIT
FIGI_COMPOSITEBBG005MX5GZ2
FIGI_SHARE_CLASSBBG005MX5H08
CIK0001650664
ISINUS28106W1036
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Editas Medicine is a clinical-stage biotechnology company developing gene-editing therapies.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.